{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:13:29Z","timestamp":1787962409011,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the science and technology department\u2019s major program of Henan, China","award":["161100311100"],"award-info":[{"award-number":["161100311100"]}]},{"name":"the national health and family planning commission in China","award":["201601010"],"award-info":[{"award-number":["201601010"]}]},{"name":"The education department\u2019s Project of Henan, China","award":["19A320052"],"award-info":[{"award-number":["19A320052"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5492-9","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T17:11:37Z","timestamp":1553706697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Performance of p16\/Ki67 immunostaining, HPV E6\/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS"],"prefix":"10.1186","volume":"19","author":[{"given":"Yuanhang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3308-2447","authenticated-orcid":false,"given":"Chenchen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"5492_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1001\/jama.2017.12439","volume":"320","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for cervical Cancer: US preventive services task force recommendation statement. JAMA. 2018;320:7.","journal-title":"JAMA"},{"key":"5492_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1309\/AJCPTGD94EVRSJCG","volume":"137","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:4.","journal-title":"Am J Clin Pathol"},{"key":"5492_CR3","doi-asserted-by":"crossref","unstructured":"A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003;188:6.","DOI":"10.1067\/mob.2003.462"},{"key":"5492_CR4","doi-asserted-by":"publisher","first-page":"536495","DOI":"10.1155\/2014\/536495","volume":"2014","author":"X Catteau","year":"2014","unstructured":"Catteau X, Simon P, No\u00ebl JC. Evaluation of the oncogenic human papillomavirus DNA test with liquid-based cytology in primary cervical Cancer screening and the importance of the ASC\/SIL ratio: a Belgian study. ISRN Obstet Gynecol. 2014;2014:536495.","journal-title":"ISRN Obstet Gynecol"},{"key":"5492_CR5","doi-asserted-by":"crossref","unstructured":"Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006;24 Suppl 3:S3\/78\u201389.","DOI":"10.1016\/j.vaccine.2006.05.117"},{"key":"5492_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AOG.0b013e3181fa7d13","volume":"116","author":"M Schiffman","year":"2010","unstructured":"Schiffman M, Wentzensen N. From human papillomavirus to cervical cancer. Obstet Gynecol. 2010;116:1.","journal-title":"Obstet Gynecol"},{"key":"5492_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"MH Mayrand","year":"2007","unstructured":"Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:16.","journal-title":"N Engl J Med"},{"key":"5492_CR8","doi-asserted-by":"crossref","unstructured":"Cox JT. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results. J Clin Virol. 2009;45 Suppl 1:S3\u2013S12.","DOI":"10.1016\/S1386-6532(09)70002-2"},{"key":"5492_CR9","first-page":"5","volume":"41","author":"AM Mills","year":"2017","unstructured":"Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH. HR-HPV E6\/E7 mRNA in situ hybridization: validation against PCR, DNA in situ hybridization, and p16 immunohistochemistry in 102 samples of cervical, vulvar, anal, and head and neck neoplasia. Am J Surg Pathol. 2017;41:5.","journal-title":"Am J Surg Pathol"},{"key":"5492_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0002-9440(10)65689-1","volume":"153","author":"T Sano","year":"1998","unstructured":"Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153:6.","journal-title":"Am J Pathol"},{"key":"5492_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1155\/2001\/950108","volume":"17","author":"KDM von","year":"2001","unstructured":"von KDM. New molecular tools for efficient screening of cervical cancer. Dis Markers. 2001;17:3.","journal-title":"Dis Markers"},{"key":"5492_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3802\/jgo.2008.19.3.162","volume":"19","author":"EJ Nam","year":"2008","unstructured":"Nam EJ, Kim JW, Hong JW, Jang HS, Lee SY, Jang SY, et al. Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol. 2008;19:3.","journal-title":"J Gynecol Oncol"},{"key":"5492_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5858\/2007-131-1343-PAKIIA","volume":"131","author":"L Iaconis","year":"2007","unstructured":"Iaconis L, Hyjek E, Ellenson LH, Pirog EC. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection. Arch Pathol Lab Med. 2007;131:9.","journal-title":"Arch Pathol Lab Med"},{"key":"5492_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.arcmed.2004.07.004","volume":"35","author":"MM Dabi\u0107","year":"2004","unstructured":"Dabi\u0107 MM, Hlupi\u0107 L, Babi\u0107 D, Juki\u0107 S, Seiwerth S. Comparison of polymerase chain reaction and catalyzed signal amplification in situ hybridization methods for human papillomavirus detection in paraffin-embedded cervical preneoplastic and neoplastic lesions. Arch Med Res. 2004;35:6.","journal-title":"Arch Med Res"},{"key":"5492_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2217\/fmb.11.87","volume":"6","author":"VV Sahasrabuddhe","year":"2011","unstructured":"Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol. 2011;6:9.","journal-title":"Future Microbiol"},{"key":"5492_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1055-9965.EPI-08-0508","volume":"17","author":"A Szarewski","year":"2008","unstructured":"Szarewski A, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomark Prev. 2008;17:11.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5492_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/1078-0432.CCR-06-2881","volume":"13","author":"PE Castle","year":"2007","unstructured":"Castle PE, Dockter J, Giachetti C, Garcia FA, McCormick MK, Mitchell AL, et al. A cross-sectional study of a prototype carcinogenic human papillomavirus E6\/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res. 2007;13:9.","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"5492_CR18","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","volume":"45","author":"J Dockter","year":"2009","unstructured":"Dockter J, Schroder A, Hill C, Guzenski L, Monsonego J, Giachetti C. Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions. J Clin Virol. 2009;45 Suppl 1:S55\u201361.","journal-title":"J Clin Virol."},{"key":"5492_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2011.02.033","volume":"121","author":"KU Petry","year":"2011","unstructured":"Petry KU, Schmidt D, Scherbring S, Luyten A, Reinecke-L\u00fcthge A, Bergeron C, et al. Triaging pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 dual-stained cytology. Gynecol Oncol. 2011;121:3.","journal-title":"Gynecol Oncol"},{"key":"5492_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cncy.20140","volume":"119","author":"D Schmidt","year":"2011","unstructured":"Schmidt D, Bergeron C, Denton KJ, Ridder R. p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol. 2011;119:3.","journal-title":"Cancer Cytopathol"},{"key":"5492_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287:16.","journal-title":"JAMA"},{"key":"5492_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1158\/1078-0432.CCR-12-0270","volume":"18","author":"N Wentzensen","year":"2012","unstructured":"Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, et al. Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18:15.","journal-title":"Clin Cancer Res"},{"key":"5492_CR23","doi-asserted-by":"crossref","unstructured":"Liu TY, Xie R, Luo L, Reilly KH, He C, Lin YZ, et al. Diagnostic validity of human papillomavirus E6\/E7 mRNA test in cervical cytological samples. J Virol Methods. 2014;196:120\u20135.","DOI":"10.1016\/j.jviromet.2013.10.032"},{"key":"5492_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/dc.2840110103","volume":"11","author":"DD Davey","year":"1994","unstructured":"Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol. 1994;11:4.","journal-title":"Diagn Cytopathol"},{"key":"5492_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00404-017-4588-1","volume":"297","author":"C Ren","year":"2018","unstructured":"Ren C, Zhu Y, Yang L, Zhang X, Liu L, Ren C. Diagnostic performance of HPV E6\/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears. Arch Gynecol Obstet. 2018;297:2.","journal-title":"Arch Gynecol Obstet"},{"key":"5492_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.vaccine.2015.12.011","volume":"34","author":"M Fakhreldin","year":"2016","unstructured":"Fakhreldin M, Elmasry K. Improving the performance of reflex human papilloma virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): a restrospective study in a tertiary hospital in United Arab Emirates (UAE). Vaccine. 2016;34:6.","journal-title":"Vaccine"},{"key":"5492_CR27","first-page":"16","volume":"7","author":"LL Yu","year":"2016","unstructured":"Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, et al. Evaluation of p16\/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China. Oncotarget. 2016;7:16.","journal-title":"Oncotarget"},{"key":"5492_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ygyno.2010.06.011","volume":"119","author":"M Reuschenbach","year":"2010","unstructured":"Reuschenbach M, Clad A, von KDC, Wentzensen N, Rahmsdorf J, Schaffrath F, et al. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results. Gynecol Oncol. 2010;119:1.","journal-title":"Gynecol Oncol"},{"key":"5492_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/1055-9965.EPI-08-0306","volume":"17","author":"K Cuschieri","year":"2008","unstructured":"Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomark Prev. 2008;17:10.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5492_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1471-0528.13076","volume":"122","author":"A Kisser","year":"2015","unstructured":"Kisser A, Zechmeister-Koss I. A systematic review of p16\/Ki-67 immuno-testing for triage of low grade cervical cytology. BJOG. 2015;122:1.","journal-title":"BJOG"},{"key":"5492_CR31","doi-asserted-by":"publisher","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","volume":"107","author":"N Wentzensen","year":"2015","unstructured":"Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, et al. p16\/Ki-67 dual stain cytology for detection of cervical Precancer in HPV-positive women. J Natl Cancer Inst. 2015;107:djv257.","journal-title":"J Natl Cancer Inst"},{"key":"5492_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.27636","volume":"132","author":"M Arbyn","year":"2013","unstructured":"Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, Ratnam S, et al. The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy. Int J Cancer. 2013;132:1.","journal-title":"Int J Cancer"},{"key":"5492_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/cncy.21325","volume":"121","author":"F Verdoodt","year":"2013","unstructured":"Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M. Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types. Cancer Cytopathol. 2013;121:12.","journal-title":"Cancer Cytopathol"},{"key":"5492_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12907-016-0032-x","volume":"16","author":"B Westre","year":"2016","unstructured":"Westre B, Giske A, Guttormsen H, S\u00f8rbye SW, Skjeldestad FE. 5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions. BMC Clin Pathol. 2016;16:9.","journal-title":"BMC Clin Pathol"},{"key":"5492_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1631\/FITEE.1601883","volume":"18","author":"YL Yao","year":"2017","unstructured":"Yao YL, Tian QF, Cheng B, Cheng YF, Ye J, Lu WG. Human papillomavirus (HPV) E6\/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women. J Zhejiang Univ Sci B. 2017;18:3.","journal-title":"J Zhejiang Univ Sci B"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5492-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5492-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5492-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T13:02:02Z","timestamp":1663160522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5492-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5492"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5492-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"31 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Ethics Committee of The Third Affiliated Hospital of Zhengzhou University. Written informed consent to participate in the study was obtained from each patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"271"}}